Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Shouji Ine"'
OX40 and IL-7 play synergistic roles in the homeostatic proliferation of effector memory CD4+T cells
Autor:
Pejman Soroosh, Satoshi Yamaki, Kazuo Sugamura, Shouji Ine, Naoto Ishii, Takeshi Sasaki, Takeshi Kawabe, Masaki Nio, Hironori Kudo, Hideo Harigae, Nobu Suzuki, Hiroyuki Nagashima, Takanori So, Shu Lan Sun, Motoshi Wada, Seyed Fazlollah Mousavi, Yuko Okuyama
Publikováno v:
European Journal of Immunology. 44:3015-3025
T-cell homeostasis preserves the numbers, the diversity and functional competence of different T-cell subsets that are required for adaptive immunity. Naive CD4+ T (TN) cells are maintained in the periphery via the common γ-chain family cytokine IL-
Autor:
Hirofumi Taji, Yoshitoyo Kagami, Dai Chihara, Yasuo Morishima, Masao Seto, Shouji Ine, Yasuhiro Oki, K Yamamoto, Hiroyasu Kato
Publikováno v:
Leukemia. 26:166-169
Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas
Autor:
Harumi Kato, Shouji Ine, Yoshitoyo Kagami, Yasuo Morishima, Kazuhito Yamamoto, Hirofumi Taji, Yasuhiro Oki, Hiroshi Onoda, Dai Chihara
Publikováno v:
European Journal of Haematology. 84:493-498
Objectives: We report a single institution experience with gastric diffuse large B-cell lymphoma (DLBCL) in an attempt to evaluate the roles of different treatment modalities, to assess the value of pretreatment positron emission tomography (PET) sca
Publikováno v:
Scopus-Elsevier
Signals through the OX40 costimulatory receptor on naive CD4 T cells are essential for full-fledged CD4 T cell activation and the generation of CD4 memory T cells. Because the ligand for OX40 is mainly expressed by APCs, including activated B cells,
Autor:
Shouji Ine, Shuming Chen, Syuichi Ikeda, Junichi Kameoka, Hideo Harigae, Takeshi Sasaki, Naoto Ishii, Pejman Soroosh, Noriyuki Kasai, Lishomwa C. Ndhlovu, Kazuo Sugamura, Taku Fujimura, Kohtaro Tada
Publikováno v:
International Immunology. 18:269-277
Adult T cell leukemia (ATL) is an aggressive neoplastic disease, in which a quarter of the patients develop opportunistic infections due to cellular immunodeficiency. However, the underlying mechanism responsible for the immunosuppression has remaine
Autor:
Shouji Ine, Masaharu Takeuchi, Nobuyo Sekiguchi, Masahiro Saitou, Toshiaki Takahashi, Satsuki Takahashi, Masato Hayashi, Etsuko Fushimi, Keiji Kimura
Publikováno v:
JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE. 52:749-754
1995年から2001年の6年間に4例の劇症型心筋炎 (男2例, 女2例, 年齢21~67歳) を経験した。診断は臨床症状, 心電図, 心エコー所見などから総合的に行い, 3例では病理学的に確定診断された。4
Autor:
Satoshi, Yamaki, Shouji, Ine, Takeshi, Kawabe, Yuko, Okuyama, Nobu, Suzuki, Pejman, Soroosh, Seyed Fazlollah, Mousavi, Hiroyuki, Nagashima, Shu-lan, Sun, Takanori, So, Takeshi, Sasaki, Hideo, Harigae, Kazuo, Sugamura, Hironori, Kudo, Motoshi, Wada, Masaki, Nio, Naoto, Ishii
Publikováno v:
European journal of immunology. 44(10)
T-cell homeostasis preserves the numbers, the diversity and functional competence of different T-cell subsets that are required for adaptive immunity. Naïve CD4(+) T (TN ) cells are maintained in the periphery via the common γ-chain family cytokine
Autor:
Dai Chihara, Hiroshi Onoda, Yasuhiro Oki, Yoshitoyo Kagami, Shouji Ine, Harumi Kato, Yasuo Morishima, Kazuhito Yamamoto, Hirofumi Taji
Publikováno v:
European Journal of Haematology. 84:84-86
Autor:
Harumi Kato, Shigeo Nakamura, Yasushi Yatabe, Kazuhito Yamamoto, Hirofumi Taji, Yasuo Morishima, Shouji Ine, Yasuhiro Oki, Dai Chihara, Yoshitoyo Kagami
Publikováno v:
Leukemialymphoma. 50(12)
We evaluated multiple patient characteristics for their prognostic significance in patients with peripheral T-cell lymphoma (angioimmunoblastic T-cell lymphoma [AITL; n = 31] and peripheral T-cell lymphoma, not otherwise unspecified [PTCL-NOS; n = 37
Autor:
Yasuhiro Oki, Yoshitoyo Kagami, Shouji Ine, Kazuhito Yamamoto, Hiroshi Onoda, Dai Chihara, Harumi Kato, Yasuo Morishima, Hirofumi Taji
Publikováno v:
Blood. 114:3703-3703
Abstract 3703 Poster Board III-639 Background Up to 40% of patients with DLBCL present with extranodal involvement of lymphoma, among which stomach is a common site. Patients with gastric DLBCL are generally treated with chemotherapy with or without